60508-9
Stage/prognostic factors section Set NAACCR v.12
Active
Panel Hierarchy
Details for each LOINC in Panel LHC-Forms
| LOINC | Name | R/O/C | Cardinality | Example UCUM Units |
|---|---|---|---|---|
| 60508-9 | Stage/prognostic factors section Set NAACCR v.12 | |||
| Indent42037-2 | Scope of regional lymph node surgery at this facility 98-02 Cancer | |||
| Indent39806-5 | Summary stage at Dx 2000 revised Cancer | |||
| Indent42038-0 | Surgery of other regional site(s), distant site(s), or distant lymph node(s) at this facility 98-02 Cancer | |||
| Indent39806-5 | Summary stage at Dx 2000 revised Cancer | |||
| Indent21887-5 | SEER summary stage 1977 Cancer | |||
| Indent21888-3 | Summary stage abbreviated at Dx Cancer | |||
| Indent21889-1 | Size Tumor | mm | ||
| Indent21890-9 | Extension Cancer | |||
| Indent21891-7 | Extent of disease Prostate cancer | |||
| Indent21892-5 | Lymph node involvement Cancer | |||
| Indent21893-3 | Regional lymph nodes positive [#] Specimen | {#} | ||
| Indent21894-1 | Regional lymph nodes examined [#] Specimen | {#} | ||
| Indent21895-8 | Extent of disease.NAACCR.old 13 digit | |||
| Indent21896-6 | Extent of disease.NAACCR.old 2 digit | |||
| Indent21897-4 | Extent of disease.NAACCR.old 4 digit | |||
| Indent21898-2 | Version used Extent of disease coding system | |||
| Indent21917-0 | Version used [Identifier] TNM classification | |||
| Indent21899-0 | Primary tumor.pathology Cancer | |||
| Indent21900-6 | Regional lymph nodes.pathology [Class] Cancer | |||
| Indent21901-4 | Distant metastases.pathology [Class] Cancer | |||
| Indent21902-2 | Stage group.pathology Cancer | |||
| Indent21903-0 | Descriptor.pathology Cancer Narrative | |||
| Indent21904-8 | Stager.pathology Cancer | |||
| Indent21905-5 | Primary tumor.clinical [Class] Cancer | |||
| Indent21906-3 | Regional lymph nodes.clinical [Class] Cancer | |||
| Indent21907-1 | Distant metastases.clinical [Class] Cancer | |||
| Indent21908-9 | Stage group.clinical Cancer | |||
| Indent21909-7 | Descriptor.clinical Cancer Narrative | |||
| Indent21910-5 | Stager.clinical Cancer | |||
| Indent21921-2 | Pediatric stage Cancer | |||
| Indent21922-0 | Coding system used Cancer pediatric staging | |||
| Indent21923-8 | Pediatric cancer stager | |||
| Indent21924-6 | Tumor marker Cancer | |||
| Indent59544-7 | Lymph-vascular invasion Cancer specimen | |||
| Indent42079-4 | Tumor size.collaborative staging | mm;cm | ||
| Indent42080-2 | Extension collaborative staging Cancer | |||
| Indent42081-0 | Collaborative staging tumor size extension evaluation Cancer | |||
| Indent42082-8 | Collaborative staging lymph nodes Cancer | |||
| Indent42083-6 | Collaborative staging regional nodes evaluation Cancer | |||
| Indent42084-4 | Collaborative staging metastasis at diagnosis Cancer | |||
| Indent42085-1 | Collaborative staging metastasis evaluation Cancer | |||
| Indent59475-4 | Collaborative staging metastasis at diagnosis - bone involvement Cancer | |||
| Indent59476-2 | Collaborative staging metastasis at diagnosis - brain involvement Cancer | |||
| Indent59477-0 | Collaborative staging metastasis at diagnosis - liver involvement Cancer | |||
| Indent59478-8 | Collaborative staging metastasis at diagnosis - lung involvement Cancer | |||
| Indent42086-9 | Collaborative staging site-Specific factor 1 Cancer | |||
| Indent42087-7 | Collaborative staging site-Specific factor 2 Cancer | |||
| Indent42088-5 | Collaborative staging site-Specific factor 3 Cancer | |||
| Indent42089-3 | Collaborative staging site-Specific factor 4 Cancer | |||
| Indent42090-1 | Collaborative staging site-Specific factor 5 Cancer | |||
| Indent42091-9 | Collaborative staging site-Specific factor 6 Cancer | |||
| Indent59489-5 | Collaborative staging site-specific factor 7 Cancer | |||
| Indent59490-3 | Collaborative staging site-specific factor 8 Cancer | |||
| Indent59491-1 | Collaborative staging site-specific factor 9 Cancer | |||
| Indent59492-9 | Collaborative staging site-specific factor 10 Cancer | |||
| Indent59493-7 | Collaborative staging site-specific factor 11 Cancer | |||
| Indent59494-5 | Collaborative staging site-specific factor 12 Cancer | |||
| Indent59495-2 | Collaborative staging site-specific factor 13 Cancer | |||
| Indent59496-0 | Collaborative staging site-specific factor 14 Cancer | |||
| Indent59497-8 | Collaborative staging site-specific factor 15 Cancer | |||
| Indent59498-6 | Collaborative staging site-specific factor 16 Cancer | |||
| Indent59499-4 | Collaborative staging site-specific factor 17 Cancer | |||
| Indent59500-9 | Collaborative staging site-specific factor 18 Cancer | |||
| Indent59501-7 | Collaborative staging site-specific factor 19 Cancer | |||
| Indent59503-3 | Collaborative staging site-specific factor 21 Cancer | |||
| Indent59504-1 | Collaborative staging site-specific factor 22 Cancer | |||
| Indent59505-8 | Collaborative staging site-specific factor 23 Cancer | |||
| Indent59506-6 | Collaborative staging site-specific factor 24 Cancer | |||
| Indent59507-4 | Collaborative staging site-specific factor 25 Cancer | |||
| Indent59488-7 | Collaborative staging pre treatment tumor size Cancer | |||
| Indent59559-5 | Collaborative staging pre treatment extension Cancer | |||
| Indent59487-9 | Collaborative staging pre treatment tumor size and extension evaluation Cancer | |||
| Indent59483-8 | Collaborative staging pre treatment lymph nodes Cancer | |||
| Indent59486-1 | Collaborative staging pre treatment regional nodes evaluation Cancer | |||
| Indent59484-6 | Collaborative staging pre treatment metastasis at diagnosis Cancer | |||
| Indent59482-0 | Collaborative staging post treatment tumor size Cancer | |||
| Indent59479-6 | Collaborative staging post treatment extension Cancer | |||
| Indent59480-4 | Collaborative staging post treatment lymph nodes Cancer | |||
| Indent59481-2 | Collaborative staging post treatment metastasis at diagnosis Cancer | |||
| Indent42094-3 | Derived American Joint Committee on Cancer T Derived | |||
| Indent42095-0 | Derived American Joint Committee on Cancer T descriptor | |||
| Indent42096-8 | Derived American Joint Committee on Cancer N | |||
| Indent42097-6 | Derived American Joint Committee on Cancer N descriptor | |||
| Indent42098-4 | Derived American Joint Committee on Cancer M | |||
| Indent42099-2 | Derived American Joint Committee on Cancer M descriptor | |||
| Indent42100-8 | Derived American Joint Committee on Cancer stage group | |||
| Indent59527-2 | Derived American Joint Committee on Cancer-7 T | |||
| Indent59528-0 | Derived American Joint Committee on Cancer-7 T descriptor | |||
| Indent59524-9 | Derived American Joint Committee on Cancer-7 N | |||
| Indent59525-6 | Derived American Joint Committee on Cancer-7 N descriptor | |||
| Indent59522-3 | Derived American Joint Committee on Cancer-7 M | |||
| Indent59523-1 | Derived American Joint Committee on Cancer-7 M descriptor | |||
| Indent59526-4 | Derived American Joint Committee on Cancer-7 stage group | |||
| Indent59539-7 | Derived pre treatment-7 T Cancer | |||
| Indent59540-5 | Derived pre treatment-7 T descriptor Cancer | |||
| Indent59536-3 | Derived pre treatment-7 N Cancer | |||
| Indent59537-1 | Derived pre treatment-7 N descriptor Cancer | |||
| Indent59534-8 | Derived pre treatment-7 M Cancer | |||
| Indent59535-5 | Derived pre treatment-7 M descriptor Cancer | |||
| Indent59538-9 | Derived pre treatment-7 stage group Cancer | |||
| Indent59533-0 | Derived post treatment-7 T Cancer | |||
| Indent59531-4 | Derived post treatment-7 N Cancer | |||
| Indent59530-6 | Derived post treatment-7 M Cancer | |||
| Indent59532-2 | Derived post treatment-7 stage group Cancer | |||
| Indent42101-6 | Derived SEER summary stage 1977 Cancer | |||
| Indent42102-4 | Derived SEER summary stage 2000 Cancer | |||
| Indent59529-8 | Flag for Derived neoadjuvant therapy not populated Cancer | |||
| Indent42103-2 | Derived American Joint Committee on Cancer conversion method | |||
| Indent42104-0 | Derived SEER summary stage 1977 conversion method Cancer | |||
| Indent42105-7 | Derived SEER summary stage 2000 conversion method Cancer | |||
| Indent59508-2 | Collaborative staging version.current Cancer | |||
| Indent42092-7 | Collaborative staging version.first Cancer | |||
| Indent42093-5 | Collaborative staging version.latest Cancer | |||
| Indent42126-3 | Comorbidities and complications 1 | |||
| Indent59858-1 | SEER site-specific fact 1 [Identifier] Cancer | |||
| Indent59859-9 | SEER site-specific fact 2 [Identifier] Cancer | |||
| Indent59860-7 | SEER site-specific fact 3 [Identifier] Cancer | |||
| Indent59861-5 | SEER site-specific fact 4 [Identifier] Cancer | |||
| Indent59862-3 | SEER site-specific fact 5 [Identifier] Cancer | |||
| Indent59863-1 | SEER site-specific fact 6 [Identifier] Cancer | |||
| Indent42116-4 | ICD revision comorbidities Cancer | |||
| Indent42126-3 | Comorbidities and complications 1 | |||
| Indent42107-3 | Comorbidities and complications 2 | |||
| Indent42108-1 | Comorbidities and complications 3 | |||
| Indent42109-9 | Comorbidities and complications 4 | |||
| Indent42110-7 | Comorbidities and complications 5 | |||
| Indent42111-5 | Comorbidities and complications 6 | |||
| Indent42112-3 | Comorbidities and complications 7 | |||
| Indent42113-1 | Comorbidities and complications 8 | |||
| Indent42114-9 | Comorbidities and complications 9 | |||
| Indent42115-6 | Comorbidities and complications 10 |
LOINC Names Get Info
- Fully-Specified Name
- Stage &or prognostic factors section:
-: Pt: ^Patient: Set: NAACCR v.12 - Long Common Name
- Stage/prognostic factors section Set NAACCR v.12
- Short Name
- Stage/prognost fact section NAACCR v.12
Part Model Get Info
- Component
- Stage &or prognostic factors section
LP73396-1
- Analyte
- Stage &or prognostic factors section
LP73396-1
- Challenge
- NULL
- Adjustment
- NULL
- Count
- NULL
- Property
- -
LP6769-6
- Time
- Pt
LP6960-1
- Time Core
- Pt
LP6960-1
- Time Modifier
- NULL
- System
- ^Patient
LP310005-6
- System Core
- NULL
- Super System
- Patient
LP6985-8
- Scale
- Set
LP7754-7
- Method
- NAACCR v.12
LP101452-3
Basic Attributes
- Class
- TUMRRGT
- Type
- Clinical
- First Released
- Version 2.34
- Last Updated
- Version 2.61 (MIN)
- Panel Type
- Panel
Member of these Panels
| LOINC | Long Common Name |
|---|---|
| 59852-4 | North American Association of Central Cancer Registries, Inc (NAACCR, Inc) version 12 panel |
Language Variants Get Info
| Tag | Language | Translation |
|---|---|---|
| el-GR | Greek (Greece) | Ενότητα Στάδιο και/ή προγνωστικοί παράγοντες: Synonyms: - NAACCR NAACCR εκδ.12 Pt Set TUMRRGT Ασθενής Ενότητα Στάδιο και/ή προγνωστικοί παράγοντες Στάδιο |
| es-MX | Spanish (Mexico) | Sección de factores de pronóstico o estadio: |
| it-IT | Italian (Italy) | Stadio &o fattori prognostici, sezione: Synonyms: Fase paziente Punto nel tempo (episodio) Registro tumori Sezione stadio/fattori prognostici |
| zh-CN | Chinese (China) | 分期和或预后因素小节: Synonyms: NAACCR 12 版; |
LOINC Terminology Service (API) using HL7® FHIR® Get Info
Requests to this service require a free LOINC username and password. Below is a sample of the possible capabilities. See the LOINC Terminology Service documentation for more information.
LOINC Copyright
Copyright © Regenstrief Institute, Inc. All Rights Reserved. To the extent included herein, the LOINC table and LOINC codes are copyright © Regenstrief Institute, Inc. and the Logical Observation Identifiers Names and Codes (LOINC) Committee. See https://